Fusitrip M Ointment combines Mometasone 0.1% w/w, a corticosteroid, and Fusidic Acid 2% w/w, an antibiotic used to treat bacterial skin infections. This dual-action formula helps reduce swelling, itching, and redness while targeting the underlying bacterial infection.
This ointment belongs to the dermatology and anti-infective segment and is widely recommended for conditions like eczema with secondary infection, dermatitis, impetigo, and infected allergic reactions. Its combination approach makes it highly effective where inflammation and bacterial contamination coexist.
The inclusion of a steroid and antibiotic makes Fusitrip M an essential prescription product in dermatology OPD setups, skin clinics, and hospital pharmacies. Due to its therapeutic importance and wide prescription range, it carries a strong repeat demand across the Indian market.
For PCD pharma franchise partners, wholesalers, and exporters, Fusitrip M Ointment offers excellent business potential in the dermatology market. It is also available for third-party manufacturing, institutional supply, and bulk distribution across India with competitive margins.